AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
- Revenue rises slightly from previous fiscal year.
- Net loss narrows significantly.
- Forecast shows future revenue growth.
Doctor Care Anywhere Group (ASX:DOC) recently released its full-year financial results for 2024. The company reported a revenue of UK£39.3 million, marking a 2.3% increase from the fiscal year 2023. The net loss stood at UK£5.14 million, a substantial 37% improvement from the previous year. Additionally, the loss per share improved to UK£0.014 from UK£0.022.
Despite these achievements, revenues fell short of analyst expectations by 3.6%, and earnings per share (EPS) missed by a notable 142%. Looking ahead, analysts project revenue to grow at an average of 11% annually over the next three years, compared to the Healthcare Services industry's 22% growth forecast in Australia.
In terms of stock performance, shares of ASX:DOC experienced a modest increase of 2.3% over the past week. However, investors should be cautious as the investment analysis for Doctor Care Anywhere Group (DOC) flags two warning signs, one of which is considered significant.
For stock investors seeking an all-in-one tool, a new portfolio management solution is available. This service allows for unlimited portfolio connections, provides alerts for new warning signs or risks, and enables tracking of the fair value of stocks. A demo version is available for those who wish to explore the features.
